Literature DB >> 16911870

Both integrated and differential regulation of components of the IL-2/IL-2 receptor system.

Hyoung Pyo Kim1, Jean Imbert, Warren J Leonard.   

Abstract

Interleukin-2 was discovered in 1976 as a T-cell growth factor. It was the first type I cytokine cloned and the first for which a receptor component was cloned. Its importance includes its multiple actions, therapeutic potential, and lessons for receptor biology, with three components differentially combining to form high, intermediate, and low-affinity receptors. IL-2Ralpha and IL-2Rbeta, respectively, are markers for double-negative thymocytes and regulatory T-cells versus memory cells. gamma(c), which is shared by six cytokines, is mutated in patients with X-linked severe-combined immunodeficiency. We now cover an under-reviewed area-the regulation of genes encoding IL-2 and IL-2R components, with an effort to integrate/explain this knowledge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911870     DOI: 10.1016/j.cytogfr.2006.07.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  127 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

Review 2.  Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.

Authors:  Stefan Bittner; Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 3.  Interleukin-2, Interleukin-7, T cell-mediated autoimmunity, and N-glycosylation.

Authors:  Ani Grigorian; Haik Mkhikian; Michael Demetriou
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

4.  Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.

Authors:  James D Lord; Robert C Hackman; Ted A Gooley; Brent L Wood; Amanda C Moklebust; David M Hockenbery; Gideon Steinbach; Steven F Ziegler; George B McDonald
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-24       Impact factor: 5.742

5.  Evaluation of clinical biomaterial surface effects on T lymphocyte activation.

Authors:  Analiz Rodriguez; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

6.  Diacylglycerol kinase ζ limits the generation of natural regulatory T cells.

Authors:  Amanda M Schmidt; Tao Zou; Rohan P Joshi; Theresa M Leichner; Matthew A Pimentel; Connie L Sommers; Taku Kambayashi
Journal:  Sci Signal       Date:  2013-11-26       Impact factor: 8.192

7.  The Nrf2 activator tBHQ inhibits T cell activation of primary human CD4 T cells.

Authors:  Alexandra E Turley; Joseph W Zagorski; Cheryl E Rockwell
Journal:  Cytokine       Date:  2014-12-05       Impact factor: 3.861

Review 8.  Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?

Authors:  Lara M Kingeter; Brian C Schaefer
Journal:  Cell Signal       Date:  2009-09-19       Impact factor: 4.315

9.  Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways.

Authors:  Xuanhe Fu; Mingkai Xu; Yubo Song; Yongqiang Li; Huiwen Zhang; Jinghai Zhang; Chenggang Zhang
Journal:  J Biol Chem       Date:  2018-10-23       Impact factor: 5.157

10.  GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; Thomas M Kaufman; Jack T Stapleton
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.